|
3. Prévention
|
|
|
|
3.3 Prévention - Vaccins
|
|
|
Merck holds parents accountable in new Gardasil ad campaign [FiercePharma]
|
|
|
|
|
|
In
the TV ad, a young adult man with cancer caused by HPV is shown in a
series of pictures that go back in time. He wonders whether his parents
just didn’t know about the vaccine that could have protected him when he
was 11 or 12. The ad ends with a female voiceover asking, “What will
you say?”
|
|
|
|
|
|
|
4. Dépistage, diagnostic et pronostic
|
|
|
|
4.10 Dép., diag. & prono. - FDA, EMA, NICE,...
|
|
|
|
5. Traitements
|
|
|
|
5.10 Traitements - Essais
|
|
|
|
|
|
|
5.12 Immunothérapies
|
|
|
|
|
5.2 Pharma
|
|
|
|
5.2.1 Pharma - Partenariats
|
|
|
Moderna Gets $200M More, Deepens Merck Ties With New Cancer Pact [Xconomy]
|
|
|
|
|
|
The
deal is industry’s latest vote of confidence in Moderna, the
high-flying yet mysterious maker of mRNA drugs. For those unfamiliar
with the company, the idea behind Moderna is to inject synthetic mRNA
strands into the body so patients’ cells can produce their own
therapeutic proteins. It’s a novel way of making drugs that is also
completely unproven in humans.
|
|
|
|
|
|
|
5.2.2 Pharma - Fusions & Acquisitions
|
|
|
|
5.2.3 Pharma - économie
|
|
|
|
5.3 Traitements - FDA, EMA,...
|
|
|
|
|
5.4 Traitements - Economie
|
|
|
|
6. Lutte contre les cancers
|
|
|
|
|
6.1 Observation
|
|
|
|
6.10.1 Politiques (USA)
|
|
|
|
|
|
|
Foundation Medicine On Biden's Cancer Moonshot: A 'Pep Rally' Can't Hurt [Forbes]
|
|
|
|
|
|
I
do believe that the vice president, as well as the members of the
Moonshot team, understand that the reimbursement barriers are some of
the greatest obstacles in the advancement of cancer care today. So we
believe it will be one of their many priorities, and they can have a
meaningful impact just by raising the issue at the national level.
That’s something that can facilitate change.
|
|
|
|
|
|
|
|
|
|
|
|
|
The Rocket Fuel for Biden’s “Cancer Moonshot”? Big Data [MIT Technology Review]
|
|
|
|
|
|
If
Vice President Joe Biden’s Cancer Moonshot is really going to double
the pace of progress in preventing, diagnosing, and treating cancer,
it’s going need a lot more data. That means it’s probably going to need
more data-sharing arrangements like one announced at today’s Cancer
Moonshot Summit in Washington, D.C., between the National Cancer
Institute and Foundation Medicine, a biotech firm selling tests that
sequence tumor genomes.
|
|
|
|
|
6.11 Patients
|
|
|
|
6.6 Publications
|
|
|
|
6.9 Controverses
|
|
|
|